DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
11
重症筋無力症
1
11. 重症筋無力症
臨床試験数
:
332
/
薬物数
:
234
- (
DrugBank
:
81
) /
標的遺伝子数
:
45
-
標的パスウェイ数
:
127
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04728425
(
ClinicalTrials.gov
)
August 28, 2020
14/7/2020
Subcutaneous Immunoglobulin for Myasthenia Gravis
Efficacy and Safety of Subcutaneous Immunoglobulin in Patients With Myasthenia Gravis
Myasthenia Gravis
Drug: subcutaneous immunoglobulin (SCIG);Drug:
intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
Drug: subcutaneous immunoglobulin (SCIG);Drug:
intravenous immunoglobulin + subcutaneous immunoglobu
...
University Health Network, Toronto
NULL
Recruiting
18 Years
100 Years
All
30
Phase 2
Canada